Adverse effects of the new generation of Rotavirus vaccine in Egyptian infants
May Mohamed Fahmy;
Abstract
The rotavirus vaccine RV1 (Rotarix; GlaxoSmithKline, Genval, Belgium) is a monovalent vaccine composed of an attenuated human rotavirus strain G1P. This parent strain was isolated during a clinical trial of an early rotavirus vaccine in 1988 (Dennehy, 200
Other data
| Title | Adverse effects of the new generation of Rotavirus vaccine in Egyptian infants | Other Titles | الأثار الجانبية للجيل الجديد لتطعيم الروتا فى الأطفال المصريين | Authors | May Mohamed Fahmy | Keywords | Adverse effects of the new generation of Rotavirus vaccine in Egyptian infants | Issue Date | 2013 | Description | The rotavirus vaccine RV1 (Rotarix; GlaxoSmithKline, Genval, Belgium) is a monovalent vaccine composed of an attenuated human rotavirus strain G1P. This parent strain was isolated during a clinical trial of an early rotavirus vaccine in 1988 (Dennehy, 200 |
Attached Files
| File | Size | Format | |
|---|---|---|---|
| 114482G1578.pdf | 386.2 kB | Adobe PDF | View/Open |
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.